Prostate trial ‘very encouraging’
"The outcome was very good. I was very pleased with the treatment and very happy with the lack of side-effects, particularly when I contrast that with what might have been the case if I'd had one of the other, alternative, treatments."
- A patient on the trial, 72-year-old Robert Page, from Croydon
A new technique to combat early prostate cancer may have far fewer side-effects than standard treatments, researchers say.
A 41-patient study in the journal Lancet Oncology suggests targeted ultrasound treatment could reduce the risk of impotence and incontinence.
Researchers say it could transform future treatment if the findings are repeated in larger studies.
The Medical Research Council (MRC), which funded the study, welcomed the results, which it said were promising.